Results 211 to 220 of about 138,819 (251)
Some of the next articles are maybe not open access.
Erenumab for episodic migraine prophylaxis
Expert Review of Neurotherapeutics, 2019Introduction: This paper reviews placebo-controlled randomized double-blind studies with erenumab for the prevention of migraine. Erenumab is a fully human monoclonal antibody (mAb), which specifically blocks the calcitonin gene-related peptide (GGRP) receptor.
Lucas Hendrik, Overeem +2 more
openaire +2 more sources
Emerging Treatments in Episodic Migraine
Current Pain and Headache Reports, 2018The purpose of this review is to evaluate and describe recent and emerging treatment options for episodic migraine.Recent advances have been made in better understanding the pathophysiology of migraine, which has led to further investigation of potential new pharmacologic and non-pharmacologic treatment options. A number of new medications are emerging
Kate W, Grimsrud, Rashmi B, Halker Singh
openaire +2 more sources
Similarities and Differences Between Chronic Migraine and Episodic Migraine
Headache: The Journal of Head and Face Pain, 2006Objective.—To quantify and characterize the similarities and the differences between chronic migraine (CM) patients with medication overuse and episodic migraine (EM) patients with only occasional analgesic use. Background.—Population‐level epidemiology, characteristics, mechanisms of chronic daily headache, and medication‐overuse ...
FERRARI, Anna +8 more
openaire +2 more sources
Hemiplegic migraine episode triggered by regadenoson
Journal of Nuclear Cardiology, 2022SPECT and PET myocardial perfusion imaging (MPI) are widely used to evaluate patients for coronary artery disease. Regadenoson (a selective A2A adenosine receptor agonist) is a commonly used vasodilator agent for stress MPI because of its safety profile and ease of use. Common adverse reactions such as headache, shortness of breath, flushing, and chest
Mohammed, Elsadany +3 more
openaire +2 more sources
The Prevalence of Chronic and Episodic Migraine in Children and Adolescents
European Journal of Neurology, 2013 Background and purpose: Migraine is the most important cause of headache leading to a decrease in the quality of life in children and adolescents. The prevalence of episodic (EM) and chronic migraine (CM) increases with increasing age, which especially ...
Caferi Tayyar Sasmaz +2 more
exaly +2 more sources
Employment and Work Impact of Chronic Migraine and Episodic Migraine
Journal of Occupational & Environmental Medicine, 2010To determine work impact of chronic migraine (CM) versus episodic migraine (EM).Data were from the 2005 American Migraine Prevalence and Prevention study, a longitudinal population survey of more than 11,000 migraineurs. Lost productive time (LPT) was measured as missed work hours plus reduced productivity hour equivalents.Those with CM were 19% less ...
Walter F, Stewart +5 more
openaire +2 more sources
Conceptualizing the relationship between chronic migraine and episodic migraine
Expert Review of Neurotherapeutics, 2009Migraine is commonly divided into two broad forms, episodic migraine (EM) and chronic migraine (CM).
Richard B, Lipton, Min Kyung, Chu
openaire +2 more sources
From Transformed Migraine to Episodic Migraine: Reversion Factors
Headache: The Journal of Head and Face Pain, 2006Objective.—To identify the factors contributing to the reversion of transformed migraine (TM) into episodic migraine. Background.—TM, the most common and important subtype of chronic daily headache (CDH), has a great effect on a patient's quality of life.
Jung Im, Seok +2 more
openaire +2 more sources
Episodic and Chronic Migraine in Children
Seminars in Neurology, 2006Migraine headaches occur frequently in both preschool and school-aged children. Although some symptoms of migraines may change with age, they are typically characterized by severe headaches in an ill-appearing child associated with photophobia and nausea and are relieved by sleep.
openaire +2 more sources
The Potential of Psychedelics for the Treatment of Episodic Migraine
Current Pain and Headache Reports, 2023This review presents the existing literature of and a framework for how psychedelic drugs might be applied as therapeutic agents in episodic migraine.The therapeutic effects of psychedelics in headache disorders have been reported for decades and controlled investigations are now beginning.
openaire +2 more sources